Mark A. Atkinson

Affiliations: 
University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Immunology, Epidemiology
Google:
"Mark Atkinson"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

F De Jesus D, Zhang Z, Brown NK, et al. (2024) Redox regulation of mA methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes. Nature Cell Biology
Foster TP, Jacobsen LM, Bruggeman B, et al. (2023) Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes Care
Beran D, Koch M, Ajmal S, et al. (2023) The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: looking back to move forward. The Lancet. Diabetes & Endocrinology
Redondo MJ, Harrall KK, Glueck DH, et al. (2023) Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes/Metabolism Research and Reviews. e3744
Shapiro MR, Dong X, Perry DJ, et al. (2023) Human immune phenotyping reveals accelerated aging in type 1 diabetes. Jci Insight
Atkinson MA, Mirmira RG. (2023) The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas. Cell Metabolism
Matsumoto R, Gray J, Rybkina K, et al. (2023) Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nature Immunology
Jacobsen LM, Diggins K, Blanchfield L, et al. (2023) Responders to low-dose ATG induce CD4 T cell exhaustion in type 1 diabetes. Jci Insight
Connors TJ, Matsumoto R, Verma S, et al. (2023) Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood. Immunity
Jung S, Nasr MB, Bahmani B, et al. (2023) Nano-Targeted Delivery of Immune Therapeutics in type 1 Diabetes. Advanced Materials (Deerfield Beach, Fla.). e2300812
See more...